A review of prostate motion with considerations for the treatment of prostate cancer
โ Scribed by Thomas E. Byrne
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 165 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0958-3947
No coin nor oath required. For personal study only.
โฆ Synopsis
The motion of the prostate gland can influence the efficacy of radiation therapy. This article examines the literature concerning prostate gland motion with considerations for the treatment of cancer. The objectives of this review include providing radiation oncologists, medical physicists, and dosimetrists with data to assist in determining the best treatment adaptation for individual patients. The prostate gland is not a static structure, but rather a dynamic structure and this should be a consideration in the treatment protocol. The treatment planning personnel must add a margin to the clinical treatment volume (CTV) radiation field to account for prostate motion and patient setup errors resulting in a planning treatment volume (PTV). The movement of the prostate in a radiation field with a small margin to protect the anterior rectum may allow the posterior aspect of the gland to escape the prescribed dose. Thus, an understanding of potential prostate movements in radiation therapy is critical to achieve tumor control and minimize radiation complications in patients.
๐ SIMILAR VOLUMES
Background. Using the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute and American total mortality rates, the authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and then subtracted the incidence of
## Abstract ## BACKGROUND. Early detection of smallโvolume prostate cancer (PCa) has led to the concept of focal therapy to treat PCa as an organโsparing, minimally invasive procedure. The authors sought to determine the frequency of unilateral cancers in the contemporary prostateโspecific antigen
## Abstract Observational studies suggest that diabetes is associated with a decreased risk of prostate cancer, but few are population based or have investigated associations with cancer stage or duration of diabetes. We report a caseโcontrol study nested within the populationโbased Prostate testin
## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the